The study of tumor immunology has led to many innovative therapeutic strategies for the treatment of melanoma. The strategies are primarily dependent on melanoma-associated antigen peptide vaccination or T-cell-based therapy. These immunotherapies are totally reliant on proper copresentation of huma
Expression of Thy-1 antigen on human melanoma cells
✍ Scribed by P. Hersey; Julienne Grace; Elaine Murray; A. Palmer; W. H. McCarthy
- Publisher
- John Wiley and Sons
- Year
- 1983
- Tongue
- French
- Weight
- 595 KB
- Volume
- 32
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
The expression of Thy‐1 was examined on fresh frozen sections of melanoma and control skin lesions using a monoclonal antibody to Thy‐1 and immunoperoxidase‐labelled second antibodies. Thy‐1 was detected on 12 of 19 primary melanomas but on only 1 of 23 melanoma metastases in lymph nodes, skin or brain. Expression of Thy‐1 did not appear related to other known histological features of primary melanoma. Thy‐1 was also expressed on 2 of 7 naevi but not on normal melanocytes or carcinoma of squamous cells, basal cells and sweat glands of the skin. Some lymphocytes below primary melanomas were Thy‐1 positive. These results suggest that Thy‐1 may be a marker of melanocytes at certain stages of differentiation analogous to its expression on cell lineages in the haemopoietic system. The relative paucity of Thy‐1 on metastases may indicate that its expression on melanoma cells has prognostic significance for behaviour of the tumour in its host.
📜 SIMILAR VOLUMES
## Abstract Previous work from our laboratory has led to the isolation of a monoclonal IgG~2a~ mouse antibody, 3.2, which is specific for an antigen, 3.1, that is strongest expressed by a group of human melanomas. We have now demonstrated that this antibody can mediate antibody‐dependent cellular c
Knowledge of tumor antigenic expression is crucial to the design of therapeutic strategy. A murine monoclonal antibody (BE4) against a human melanoma membrane antigen, was used to study the in vitro expression of this antigen. By membrane immunofluorescence, BE4 reacted against 5 of 8 melanoma lines
Delayed hypersensitivity reactions to soluble components of the cell membranes of autologous a n d allogeneic tumors were elicited in a series of patients with malignant melanoma. T w o skin reactive antigens were prepared using stepwise low frequency sonication of cell membranes, chromatography of
## Abstract Antibody‐dependent cell‐mediated cytotoxic assays have been used to examine antigens on human melanoma cells obtained either directly from patients or from long‐term melanoma cell lines. A panel of melanoma antisera was selected from human subjects which could be shown not to have signi